These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18399000)

  • 1. HIV-1 vaccine candidate ineffective.
    Barouch DH
    AIDS Clin Care; 2007 Nov; 19(11):93. PubMed ID: 18399000
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines. From Brazil and France: a vaccine against HIV may lower viral load.
    TreatmentUpdate; 2005; 17(1):10-1. PubMed ID: 17228459
    [No Abstract]   [Full Text] [Related]  

  • 3. Top stories of 2008. Crash and burn of HIV vaccine candidates.
    del Rio C
    AIDS Clin Care; 2009 Jan; 21(1):4. PubMed ID: 19219958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus vectors as HIV-1 vaccines: where are we? What next?
    DʼSouza MP; Yang OO
    AIDS; 2015 Feb; 29(4):395-400. PubMed ID: 25630039
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV/AIDS vaccines: a need for new concepts?
    Girard MP; Bansal GP
    Int Rev Immunol; 2008; 27(6):447-71. PubMed ID: 19065351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 T-cell vaccines: evaluating the next step.
    Pantaleo G
    Lancet Infect Dis; 2008 Feb; 8(2):82-3. PubMed ID: 18060842
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new veil removed from the physiologic mysteries of "HIV control" ].
    Nau JY
    Rev Med Suisse; 2007 Apr; 3(107):1017. PubMed ID: 17526378
    [No Abstract]   [Full Text] [Related]  

  • 8. Human versus HIV: round 2 defeat in AIDS vaccine development.
    Lu S
    Expert Rev Vaccines; 2008 Mar; 7(2):151-3. PubMed ID: 18324884
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunity's yin and yang. A successful vaccine must first avoid being eliminated by pre-existing immunity before it can promote a protective immune response.
    Cohen P
    IAVI Rep; 2006; 10(1):1-5. PubMed ID: 16625717
    [No Abstract]   [Full Text] [Related]  

  • 10. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.
    Cukalac T; Moffat JM; Venturi V; Davenport MP; Doherty PC; Turner SJ; Stambas J
    Vaccine; 2009 Nov; 27(48):6755-61. PubMed ID: 19744584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Battling the enemy on many fronts: inside the science of HIV vaccine development.
    Talley A; Chang S
    Body Posit; 2004; 17(4):8-12. PubMed ID: 15929208
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccines for HIV--looking to the future.
    TreatmentUpdate; 2004 Oct; 16(6):1-3. PubMed ID: 17219677
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV adenovirus vaccine in Phase I trials.
    Expert Rev Vaccines; 2003 Aug; 2(4):471. PubMed ID: 14711332
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV vaccine uses lentivector.
    AIDS Patient Care STDS; 2008 Apr; 22(4):352-3. PubMed ID: 18434952
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
    Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
    Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials yield promising results from two adenovirus-based vaccines.
    IAVI Rep; 2005; 9(4):24. PubMed ID: 16465689
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccines. Vaccines as therapy.
    TreatmentUpdate; 2005; 17(1):9-10. PubMed ID: 17228403
    [No Abstract]   [Full Text] [Related]  

  • 19. One step forward, two steps back--will there ever be an AIDS vaccine?
    Steinbrook R
    N Engl J Med; 2007 Dec; 357(26):2653-5. PubMed ID: 18160684
    [No Abstract]   [Full Text] [Related]  

  • 20. Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location.
    Masopust D
    J Intern Med; 2009 Jan; 265(1):125-37. PubMed ID: 19093965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.